Recipients of cadaver-derived pituitary growth hormone (c-hGH) developed biomarker changes in the realm of Alzheimer’s disease (AD).
Median lag between FDA authorization and Medicare coverage hits 6 years: study
Dive Brief: Fewer than 30% of novel medical devices receive nominal or better coverage from Medicare in the three years after regulatory authorization, according to
August 11, 2023